Cooley has advised Navan, and Fenwick & West has advised the underwriters. Navan, Inc., an all-in-one business travel, payments, and expense management platform, has completed its...
You must be a Standard 1 Year member to access this content.
Weil has advised Advent International and its portfolio company Xplor Technologies. Cooley has advised Clubessential Holdings. Xplor Technologies, a global platform specializing in software and embedded...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis has advised Firefly Aerospace. Cooley has advised SciTec. Firefly Aerospace, a leading space and defense technology company, has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised Eli Lilly and Company, and Cooley has advised Adverum Biotechnologies, Inc. Eli Lilly and Company has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Cooley has advised Electra Therapeutics, and Gibson Dunn has advised Nextech Ventures and EQT Life Sciences. Electra Therapeutics, a clinical-stage biotechnology company focused on developing therapies...
You must be a Standard 1 Year member to access this content.
Cooley has advised Veritone, Inc. White & Case has advised Needham & Company, LLC. Veritone, Inc. has completed a registered direct offering of approximately 12.9 million...
You must be a Standard 1 Year member to access this content.
McDermott Will & Schulte has advised ADAR1 Capital Management. Cooley has advised Keros Therapeutics. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced a major capital...
You must be a Standard 1 Year member to access this content.
WilmerHale has advised Ocular Therapeutix and Cooley has advised the underwriters. Ocular Therapeutix, Inc., an integrated biopharmaceutical company, conducted an underwritten offering of 37,909,018 shares of...
You must be a Standard 1 Year member to access this content.
Paul Hastings has advised TD Cowen, Leerink Partners, and Oppenheimer & Co. Cooley LLP has advised Ovid Therapeutics Inc. Ovid Therapeutics Inc., a biopharmaceutical company listed...
You must be a Standard 1 Year member to access this content.
Cooley has advised Y-mAbs Therapeutics, while Wilson Sonsini Goodrich & Rosati has advised Centerview Partners, financial advisor to Y-mAbs Therapeutics. SERB Pharmaceuticals, a global specialty pharmaceutical...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis has advised Syndigo, and Cooley has advised 1WorldSync. Syndigo, a global leader in Product Experience Management (PXM) solutions, has acquired 1WorldSync in a...
You must be a Standard 1 Year member to access this content.
Cooley and Wilson Sonsini Goodrich & Rosati have advised Enlaza Therapeutics, and Covington has advised Vertex Pharmaceuticals. Enlaza Therapeutics has entered into a multi-target drug discovery...
You must be a Standard 1 Year member to access this content.
